StockData
Palvella Therapeutics, Inc. logo

Palvella Therapeutics, Inc. (PVLA) bonds

PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$144.35−0.25 (-0.17%)

Close on Nov 17, 2026Market cap $2.08BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Palvella Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Palvella Therapeutics's 10-K for the period ended Dec 31, 2025

IssueCarrying value
Note 1
Convertible
$5.00M
Note 10
Convertible
$20.00K
Note 11
Convertible
$700.00K
Note 12
Convertible
$500.00K
Note 13
Convertible
$150.00K
Note 14
Convertible
$500.00K
Note 15
Convertible
$1.00M
Note 16
Convertible
$2.00M
Note 17
Convertible
$3.00M
Note 2
Convertible
$2.50M
Note 3
Convertible
$2.50M
Note 4
Convertible
$50.00K
Note 5
Convertible
$50.00K
Note 6
Convertible
$150.00K
Note 7
Convertible
$143.00K
Note 8
Convertible
$100.00K
Note 9
Convertible
$70.00K

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.

See a number that looks wrong?